Influence of endogenous NEFA on beta cell function in humans

Eleni Rebelos, Marta Seghieri, Andrea Natali, Beverly Balkau, Alain Golay, Pier Marco Piatti, Nebojsa M. Lalic, Markku Laakso, Andrea Mari, Ele Ferrannini

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Aims/hypothesis: It is a commonly held view that chronically elevated NEFA levels adversely affect insulin secretion and insulin action (lipotoxicity). However, the effect of NEFA on beta cell function has only been explored using acute NEFA elevations. Our aim was to analyse the relationship between endogenous NEFA levels and beta cell function. Methods: In 1,267 individuals followed-up for 3 years, we measured insulin sensitivity (by clamp) and beta cell function (by C-peptide modelling during OGTT and as the acute insulin response [AIR] to IVGTT). Results: At baseline, both fasting and insulin-suppressed NEFA levels were higher across glucose tolerance groups, while insulin sensitivity was lower, insulin output was higher, and beta cell glucose sensitivity and AIR were lower (all p <0.0001). In multiple logistic analyses adjusting for age, BMI, WHR and glucose tolerance, both fasting and insulin-suppressed NEFA levels were inversely related to insulin sensitivity, as expected (both p <0.0001). Furthermore, after adjusting for insulin sensitivity, insulin-suppressed NEFA were positively associated with total insulin output (p = 0.0042). In contrast, neither fasting nor insulin-suppressed NEFA were related to beta cell glucose sensitivity or AIR. At follow-up, worsening of glucose tolerance (n = 126) was predicted by lower insulin and beta cell glucose sensitivity. In this model, baseline NEFA were not significant predictors of progression. Conclusions/interpretation: In the non-diabetic state and in subjects with impaired glucose tolerance, circulating endogenous NEFA are not independently associated measures of beta cell function, and do not predict deterioration of glucose tolerance. Thus, in the Relationship Between Insulin Sensitivity and Cardiovascular Disease (RISC) cohort there is no evidence for beta cell lipotoxicity of endogenous total NEFA concentrations.

Original languageEnglish
Pages (from-to)2344-2351
Number of pages8
JournalDiabetologia
Volume58
Issue number10
DOIs
Publication statusPublished - Oct 24 2015

Fingerprint

Nonesterified Fatty Acids
Insulin
Insulin Resistance
Glucose
Fasting
Glucose Intolerance
C-Peptide
Glucose Tolerance Test
Cardiovascular Diseases

Keywords

  • Beta cell function
  • Beta cell glucose sensitivity
  • Glucose intolerance
  • Insulin resistance
  • Lipotoxicity
  • NEFA

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Rebelos, E., Seghieri, M., Natali, A., Balkau, B., Golay, A., Piatti, P. M., ... Ferrannini, E. (2015). Influence of endogenous NEFA on beta cell function in humans. Diabetologia, 58(10), 2344-2351. https://doi.org/10.1007/s00125-015-3685-6

Influence of endogenous NEFA on beta cell function in humans. / Rebelos, Eleni; Seghieri, Marta; Natali, Andrea; Balkau, Beverly; Golay, Alain; Piatti, Pier Marco; Lalic, Nebojsa M.; Laakso, Markku; Mari, Andrea; Ferrannini, Ele.

In: Diabetologia, Vol. 58, No. 10, 24.10.2015, p. 2344-2351.

Research output: Contribution to journalArticle

Rebelos, E, Seghieri, M, Natali, A, Balkau, B, Golay, A, Piatti, PM, Lalic, NM, Laakso, M, Mari, A & Ferrannini, E 2015, 'Influence of endogenous NEFA on beta cell function in humans', Diabetologia, vol. 58, no. 10, pp. 2344-2351. https://doi.org/10.1007/s00125-015-3685-6
Rebelos E, Seghieri M, Natali A, Balkau B, Golay A, Piatti PM et al. Influence of endogenous NEFA on beta cell function in humans. Diabetologia. 2015 Oct 24;58(10):2344-2351. https://doi.org/10.1007/s00125-015-3685-6
Rebelos, Eleni ; Seghieri, Marta ; Natali, Andrea ; Balkau, Beverly ; Golay, Alain ; Piatti, Pier Marco ; Lalic, Nebojsa M. ; Laakso, Markku ; Mari, Andrea ; Ferrannini, Ele. / Influence of endogenous NEFA on beta cell function in humans. In: Diabetologia. 2015 ; Vol. 58, No. 10. pp. 2344-2351.
@article{7621a649843d4344aaf0063b6828ede4,
title = "Influence of endogenous NEFA on beta cell function in humans",
abstract = "Aims/hypothesis: It is a commonly held view that chronically elevated NEFA levels adversely affect insulin secretion and insulin action (lipotoxicity). However, the effect of NEFA on beta cell function has only been explored using acute NEFA elevations. Our aim was to analyse the relationship between endogenous NEFA levels and beta cell function. Methods: In 1,267 individuals followed-up for 3 years, we measured insulin sensitivity (by clamp) and beta cell function (by C-peptide modelling during OGTT and as the acute insulin response [AIR] to IVGTT). Results: At baseline, both fasting and insulin-suppressed NEFA levels were higher across glucose tolerance groups, while insulin sensitivity was lower, insulin output was higher, and beta cell glucose sensitivity and AIR were lower (all p <0.0001). In multiple logistic analyses adjusting for age, BMI, WHR and glucose tolerance, both fasting and insulin-suppressed NEFA levels were inversely related to insulin sensitivity, as expected (both p <0.0001). Furthermore, after adjusting for insulin sensitivity, insulin-suppressed NEFA were positively associated with total insulin output (p = 0.0042). In contrast, neither fasting nor insulin-suppressed NEFA were related to beta cell glucose sensitivity or AIR. At follow-up, worsening of glucose tolerance (n = 126) was predicted by lower insulin and beta cell glucose sensitivity. In this model, baseline NEFA were not significant predictors of progression. Conclusions/interpretation: In the non-diabetic state and in subjects with impaired glucose tolerance, circulating endogenous NEFA are not independently associated measures of beta cell function, and do not predict deterioration of glucose tolerance. Thus, in the Relationship Between Insulin Sensitivity and Cardiovascular Disease (RISC) cohort there is no evidence for beta cell lipotoxicity of endogenous total NEFA concentrations.",
keywords = "Beta cell function, Beta cell glucose sensitivity, Glucose intolerance, Insulin resistance, Lipotoxicity, NEFA",
author = "Eleni Rebelos and Marta Seghieri and Andrea Natali and Beverly Balkau and Alain Golay and Piatti, {Pier Marco} and Lalic, {Nebojsa M.} and Markku Laakso and Andrea Mari and Ele Ferrannini",
year = "2015",
month = "10",
day = "24",
doi = "10.1007/s00125-015-3685-6",
language = "English",
volume = "58",
pages = "2344--2351",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "10",

}

TY - JOUR

T1 - Influence of endogenous NEFA on beta cell function in humans

AU - Rebelos, Eleni

AU - Seghieri, Marta

AU - Natali, Andrea

AU - Balkau, Beverly

AU - Golay, Alain

AU - Piatti, Pier Marco

AU - Lalic, Nebojsa M.

AU - Laakso, Markku

AU - Mari, Andrea

AU - Ferrannini, Ele

PY - 2015/10/24

Y1 - 2015/10/24

N2 - Aims/hypothesis: It is a commonly held view that chronically elevated NEFA levels adversely affect insulin secretion and insulin action (lipotoxicity). However, the effect of NEFA on beta cell function has only been explored using acute NEFA elevations. Our aim was to analyse the relationship between endogenous NEFA levels and beta cell function. Methods: In 1,267 individuals followed-up for 3 years, we measured insulin sensitivity (by clamp) and beta cell function (by C-peptide modelling during OGTT and as the acute insulin response [AIR] to IVGTT). Results: At baseline, both fasting and insulin-suppressed NEFA levels were higher across glucose tolerance groups, while insulin sensitivity was lower, insulin output was higher, and beta cell glucose sensitivity and AIR were lower (all p <0.0001). In multiple logistic analyses adjusting for age, BMI, WHR and glucose tolerance, both fasting and insulin-suppressed NEFA levels were inversely related to insulin sensitivity, as expected (both p <0.0001). Furthermore, after adjusting for insulin sensitivity, insulin-suppressed NEFA were positively associated with total insulin output (p = 0.0042). In contrast, neither fasting nor insulin-suppressed NEFA were related to beta cell glucose sensitivity or AIR. At follow-up, worsening of glucose tolerance (n = 126) was predicted by lower insulin and beta cell glucose sensitivity. In this model, baseline NEFA were not significant predictors of progression. Conclusions/interpretation: In the non-diabetic state and in subjects with impaired glucose tolerance, circulating endogenous NEFA are not independently associated measures of beta cell function, and do not predict deterioration of glucose tolerance. Thus, in the Relationship Between Insulin Sensitivity and Cardiovascular Disease (RISC) cohort there is no evidence for beta cell lipotoxicity of endogenous total NEFA concentrations.

AB - Aims/hypothesis: It is a commonly held view that chronically elevated NEFA levels adversely affect insulin secretion and insulin action (lipotoxicity). However, the effect of NEFA on beta cell function has only been explored using acute NEFA elevations. Our aim was to analyse the relationship between endogenous NEFA levels and beta cell function. Methods: In 1,267 individuals followed-up for 3 years, we measured insulin sensitivity (by clamp) and beta cell function (by C-peptide modelling during OGTT and as the acute insulin response [AIR] to IVGTT). Results: At baseline, both fasting and insulin-suppressed NEFA levels were higher across glucose tolerance groups, while insulin sensitivity was lower, insulin output was higher, and beta cell glucose sensitivity and AIR were lower (all p <0.0001). In multiple logistic analyses adjusting for age, BMI, WHR and glucose tolerance, both fasting and insulin-suppressed NEFA levels were inversely related to insulin sensitivity, as expected (both p <0.0001). Furthermore, after adjusting for insulin sensitivity, insulin-suppressed NEFA were positively associated with total insulin output (p = 0.0042). In contrast, neither fasting nor insulin-suppressed NEFA were related to beta cell glucose sensitivity or AIR. At follow-up, worsening of glucose tolerance (n = 126) was predicted by lower insulin and beta cell glucose sensitivity. In this model, baseline NEFA were not significant predictors of progression. Conclusions/interpretation: In the non-diabetic state and in subjects with impaired glucose tolerance, circulating endogenous NEFA are not independently associated measures of beta cell function, and do not predict deterioration of glucose tolerance. Thus, in the Relationship Between Insulin Sensitivity and Cardiovascular Disease (RISC) cohort there is no evidence for beta cell lipotoxicity of endogenous total NEFA concentrations.

KW - Beta cell function

KW - Beta cell glucose sensitivity

KW - Glucose intolerance

KW - Insulin resistance

KW - Lipotoxicity

KW - NEFA

UR - http://www.scopus.com/inward/record.url?scp=84942124504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942124504&partnerID=8YFLogxK

U2 - 10.1007/s00125-015-3685-6

DO - 10.1007/s00125-015-3685-6

M3 - Article

C2 - 26160433

AN - SCOPUS:84942124504

VL - 58

SP - 2344

EP - 2351

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 10

ER -